Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluationOriginal Research Published on 2021-02-192022-10-29 Journal: Journal of Clinical Pathology [Category] COVID-19, COVID19(2023년), MERS, SARS, [키워드] 28-day mortality 95% CI adjusted Admission Admissions age Analysis Biochemistry blood test C reactive protein clinical component composite endpoint conducted costs and cost analysis COVID-19 COVID-19 positive patient D-dimer Deprivation determine died Electrolytes Escalation estimate Examining ferritin First wave full blood count Gender global pandemic Haematology healthcare IMPROVE indications Infection infections Inflammation intensive care Laboratory Laboratory testing laboratory-confirmed lactate dehydrogenase Liver function test Local Mortality multivariable logistic regression outcome pathway Patient poor prognosis predict procalcitonin prognostic Prognostic value reached remains uncertain resource Result retrospective risk risk stratification SARS-CoV-2 the primary endpoint troponin I unique urea utility variable with COVID-19 [DOI] 10.1136/jclinpath-2020-207157 PMC 바로가기 [Article Type] Original Research
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19Brief Report Published on 2021-02-172022-10-28 Journal: Pathogens [Category] COVID-19, [키워드] addition Adverse reaction Analysis antiviral drug article cause caused Chloroquine clinical trial combating Combination coronavirus disease COVID-19 Efficacy HCQ Hydroxychloroquine life-threatening Modification observation outcome Patient performed QTC prolongation remains uncertain searched Seven severe COVID-19 severe COVID-19 patients Side effects suggested systematic review Treatment Web of Science were used [DOI] 10.3390/pathogens10020217 PMC 바로가기 [Article Type] Brief Report
Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment?종양 환자의 비인두 면봉에서 장기간 SARS-CoV-2-RNA 검출: 암 치료에 어떤 영향을 미칩니까?Case Reports Published on 2021-02-082022-09-11 Journal: Current Oncology [Category] MERS, 치료기술, [키워드] absence affecting association Cancer cancer patient Cancer patients cancer treatment Cell clinical symptom Clinical symptoms complications COVID-19 Culture detection diagnosis of SARS-CoV-2 diagnostic exhibited Impact Infection Isolation lung cancer lung cancer patient lung cancer patients management measure nasopharyngeal Nasopharyngeal swab nasopharyngeal swabs Non-small cell lung cancer overlap pandemic Patient PCR assays Prolonged Radiotherapy remains uncertain risk RT-PCR assay RT-PCR assays SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV-2 viral symptoms of infection the patient Trachea Viral viral culture [DOI] 10.3390/curroncol28010083 PMC 바로가기 [Article Type] Case Reports
Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-AnalysisCardiovascular Medicine Published on 2021-01-082022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] 95% CI Analysis Cohort confidence interval coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Critically ill Deep venous thrombosis dosage DVT—deep vein thrombosis event Exploratory analysis ICU Ill item Meta-analysis Patient patients performed Prevalence prevalence rates Prophylactic proportion Randomized controlled trials recent reduce remains uncertain Reporting review SARS-CoV-2 searched significantly subgroup analysis systematic review therapeutic anticoagulation Thromboprophylaxis thrombosis venous Venous Thromboembolism VTE VTE risk [DOI] 10.3389/fcvm.2020.598846 PMC 바로가기 [Article Type] Cardiovascular Medicine
Lack of Antibodies to SARS-CoV-2 among Blood Donors during COVID-19 Lockdown: A Study from Saudi ArabiaArticle Published on 2021-01-052022-10-31 Journal: International journal for equity in health [Category] COVID-19, [키워드] acute respiratory syndrome antibodies antibody blood donor Blood donors chemiluminescence immunoassay CLIA coronavirus coronavirus disease country COVID-19 COVID-19 case diagnosed Effectiveness ELISA enzyme-linked immunosorbent evaluate General population groups healthcare services healthy blood donor hospital Hypothesis incidence rate Infection lack lockdown measure microneutralization molecular assays reduce remains uncertain risk Sample SARS-CoV-2 Saudi Arabia Seroprevalence Spread study period Support [DOI] 10.3390/healthcare9010051 PMC 바로가기 [Article Type] Article
Hypertension, medications, and risk of severe COVID-19: A Massachusetts community-based observational studyObservational Study Published on 2021-01-012022-10-05 Journal: Journal of clinical hypertension (Greenwich, Conn. [Category] SARS, 임상, [키워드] 95% CI age analyses angiotensin receptor blocker Angiotensin receptor blockers Angiotensin-converting enzyme angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors anticoagulant medication ARB association Beta blockers Cancer cardiovascular disease Comorbidity COVID-19 COVID-19 diagnosis defined diabete diagnosed with COVID-19 elevated evaluated exacerbate health condition Hospitalization hypertension increased risk individual inhibitor investigated less Massachusett medication medications mitigate modify Mortality outcomes Patient Prevent RAS receptor recommendation remains uncertain renin-angiotensin system risk SARS-COV-2 infection severe coronavirus disease severe COVID-19 severity Support Thiazide with COVID-19 [DOI] 10.1111/jch.14101 PMC 바로가기 [Article Type] Observational Study
Update on COVID-19 MyocarditisCOVID-19 심근염에 대한 업데이트Review Published on 2020-12-092022-09-10 Journal: Medicina [Category] MERS, SARS, 치료제, [키워드] Acute coronary syndrome acute respiratory syndrome addition Affect arrhythmia Arrhythmias cardiac Cardiac complications Cardiogenic shock Complication convalescent plasma coronary syndrome coronavirus coronavirus 2 COVID-19 COVID-19 disease current Diagnosis Endomyocardial biopsy etiologies Evidence expected heart failure Host immune response human body imaging modality include increasingly Injury Intervention key factor Laboratory laboratory findings life life threatening life-threatening management manifestation morbidity morbidity and mortality MRI myocarditis Non-invasive organ system organ systems performed reducing refractory remains uncertain Remdesivir respiratory respiratory distress Respiratory distress syndrome Respiratory system SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe COVID-19 disease Severe respiratory distress Shock Steroids Support syndrome therapy Viral while [DOI] 10.3390/medicina56120678 PMC 바로가기 [Article Type] Review
Robust neutralizing antibodies to SARS-CoV-2 infection persist for monthsSARS-CoV-2 감염에 대한 강력한 중화 항체는 몇 달 동안 지속됩니다.Report Published on 2020-12-042022-09-12 Journal: Science (New York, N.y.) [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Anti-spike Antibody Response Antibody titers binding caused chance Cohort coronavirus COVID-19 COVID-19 case dataset detectable determine global pandemic humoral immune response Immunoglobulin Immunoglobulin G individual infected individual infected individuals Infection Longevity majority Mild mild to moderate Mild-to-moderate moderate Moderate COVID-19 Mount Sinai Mount Sinai Health System neutralization Neutralizing neutralizing antibody neutralizing antibody responses Neutralizing antibody titer neutralizing antibody titers New York City potency Reinfection remains uncertain respiratory robust robustness SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 spike protein Science screened severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly Spike protein Symptom System the antibody response the SARS-CoV-2 titers Viral viral spike protein virus [DOI] 10.1126/science.abd7728 PMC 바로가기 [Article Type] Report
Could KL-6 levels in COVID-19 help to predict lung disease?COVID-19의 KL-6 수치가 폐 질환을 예측하는 데 도움이 될 수 있습니까?Letter to the Editor Published on 2020-11-242022-08-31 Journal: Respiratory Research [Category] 바이오마커, [키워드] affected Biomarker bronchial epithelial cells cellular Cohort collected composed coronavirus coronavirus disease COVID-19 COVID-19 infected patient COVID-19 infection COVID-19 patient determine Diagnosis disease disease severity effective epithelial epithelial cells Evolution glycoprotein healthy subject healthy subjects help heterogenous ILD Increased International Interstitial lung disease Interstitial lung diseases IPF KL-6 Laboratory lesion lung Lung disease Lung diseases Lung infection marker material molecular weight Patient predict produced Prognosis public health emergency quest question raised remains uncertain Result sarcoidosis serum Serum level severity therapeutic response Treatment Type II pneumocyte type II pneumocytes [DOI] 10.1186/s12931-020-01560-4 PMC 바로가기 [Article Type] Letter to the Editor
Association of glycosylated hemoglobin and outcomes in patients with COVID-19 and pre-existing type 2 diabetes A protocol for systematic review and meta-analysis4300 Published on 2020-11-202022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] approval association blood glucose Chinese Clinical practice CNKI cohort study coronavirus disease COVID-19 death died Disabled English Ethics Evidence for inclusion glycosylated glycosylated hemoglobin hemoglobin heterogeneity information Meta-analysis Mortality outcome participant Patient patients with COVID-19 peer-reviewed protocol provided Randomized controlled trial RCTs Regulation remained remains uncertain reported searched sensitivity subgroup analysis systematic review T2D Trial trials type 2 diabete type 2 diabetes [DOI] 10.1097/MD.0000000000023392 PMC 바로가기 [Article Type] 4300